FDA Approves Galafold™ (migalastat) for the Treatment of Certain Adult Patients with Fabry Disease

World News: . []

CRANBURY NJ Aug 10 2018 GLOBE NEWSWIRE -- Amicus Therapeutics Nasdaq FOLD today announced that the US Food and Drug Administration FDA has granted accelerated approval of Galafoldmigalastat 123 mg capsules Galafold is an ora l, prec...

More news and information about Amicus Therapeutics, Inc.

Published By:

Globe Newswire: 21:05 GMT Friday 10th August 2018

Published: .

Search for other references to "approves" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us